The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Glybochko P.V.

Sechenov First Moscow State Medical University of the Russian Healthcare Ministry, Research Institute of Uronephrology and Human Reproductive Health, Moscow, Russia

Mukhin N.A.

GBOU VPO «Pervyj Moskovskij gosudarstvennyj meditsinskij universitet im. I.M. Sechenova», Moskva

Svistunov A.A.

Federal State Autonomous Educational Institution of Higher Education «I.M. Sechenov First Moscow State Medical University» of the Ministry of Healthcare of the Russia Department of Polyclinic Therapy of the Faculty of Medicine, Moscow, Russia

Fomin V.V.

I.M. Sechenov First State Moscow Medical University

Brovko M.Yu.

Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation, Moscow, Russia

Varshavskiĭ V.A.

Kafedra patologicheskoĭ anatomii im. A.I. Strukova GBOU VPO "Pervyĭ Moskovskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. I.M. Sechenova" Minzdrava Rossii

Moiseev S.V.

Kafedra terapii i profbolezneĭ Pervogo moskovskogo gosudarstvennogo meditsinskogo universiteta im. I.M. Sechenova, MGU im. M.V. Lomonosova

Shilov E.M.

Kafedra nefrologii

Panasiuk V.V.

Klinika nefrologii, vnutrennikh i professional'nykh zabolevaniĭ, Universitetskaia klinicheskaia bol'nitsa #3 Pervogo MGMU im. I.M. Sechenova, Moskva

Morphological verification of renal lesion as a compulsory stage in the diagnosis of Fabry disease

Authors:

Glybochko P.V., Mukhin N.A., Svistunov A.A., Fomin V.V., Brovko M.Yu., Varshavskiĭ V.A., Moiseev S.V., Shilov E.M., Panasiuk V.V.

More about the authors

Journal: Therapeutic Archive. 2014;86(12): 31‑34

Read: 1135 times

Contact the author
Table of contents

MORPHOLOGICAL VERIFICATION OF RENAL LESION AS A COMPULSORY STAGE IN THE DIAGNOSIS OF FABRY DISEASE
MORPHOLOGICAL VERIFICATION OF RENAL LESION AS A COMPULSORY STAGE IN THE DIAGNOSIS OF FABRY DISEASE

To cite this article:

Glybochko PV, Mukhin NA, Svistunov AA, et al. . Morphological verification of renal lesion as a compulsory stage in the diagnosis of Fabry disease. Therapeutic Archive. 2014;86(12):31‑34.

МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Abstract:

The paper describes a case of Fabry disease in a patient in whom kidney biopsy enabled the renal lesion be characterized in detail. Fabry nephropathy-associated kidney tissue changes, including renal lesion, have been verified using electron microscopy of renal tissue.

Keywords:

kidney biopsy
Fabry disease
renal lesion
rare (orphan) diseases.

Authors:

Glybochko P.V.

Sechenov First Moscow State Medical University of the Russian Healthcare Ministry, Research Institute of Uronephrology and Human Reproductive Health, Moscow, Russia

Mukhin N.A.

GBOU VPO «Pervyj Moskovskij gosudarstvennyj meditsinskij universitet im. I.M. Sechenova», Moskva

Svistunov A.A.

Federal State Autonomous Educational Institution of Higher Education «I.M. Sechenov First Moscow State Medical University» of the Ministry of Healthcare of the Russia Department of Polyclinic Therapy of the Faculty of Medicine, Moscow, Russia

Fomin V.V.

I.M. Sechenov First State Moscow Medical University

Brovko M.Yu.

Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation, Moscow, Russia

Varshavskiĭ V.A.

Kafedra patologicheskoĭ anatomii im. A.I. Strukova GBOU VPO "Pervyĭ Moskovskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. I.M. Sechenova" Minzdrava Rossii

Moiseev S.V.

Kafedra terapii i profbolezneĭ Pervogo moskovskogo gosudarstvennogo meditsinskogo universiteta im. I.M. Sechenova, MGU im. M.V. Lomonosova

Shilov E.M.

Kafedra nefrologii

Panasiuk V.V.

Klinika nefrologii, vnutrennikh i professional'nykh zabolevaniĭ, Universitetskaia klinicheskaia bol'nitsa #3 Pervogo MGMU im. I.M. Sechenova, Moskva

Close metadata

References:

  1. Desnick R., Ioannou Y., Eng C.  Alpha-Galactosidase A deficiency: Fabry disease. In: Scriver C.R. B.A., Sly W.S., Valle D. ed. The Metabolic and Molecular Bases of Inherited Disease. 8th ed. New York: McGraw-Hill; 2001: 3733-3774.
  2. Фомин В.В., Пулин А.А., Аксенова О.А. и др.  Tyazheloe porazhenie podotsitov, vyyavlennoe pri elektronnoi mikroskopii pochechnogo bioptata, u patsienta s bolezn'yu Fabri bez vyrazhennykh izmenenii mochi i pochechnoi nedostatochnosti. Klinich nefrologiya 2012; 1: 55-58.
  3. Ortiz A., Cianciaruso B., Cizmarik M. et al.  End-stage renal disease in patients with Fabry disease: natural history data from the Fabry Registry. Nephrol Dial Transplant 2010; 25: 769-775.
  4. Schiffmann R., Warnock D.G., Banikazemi M. et al.  Fabry disease: progression of nephropathy, and prevalence of cardiac and cerebrovascular events before enzyme replacement therapy. Nephrol Dial Transplant 2009; 24: 2102-2111.
  5. Branton M.H., Schiffmann R., Sabnis S.G. et al.  Natural history of Fabry renal disease: influence of alpha-galactosidase A activity and genetic mutations on clinical course. Medicine (Baltimore) 2002; 81: 122-138.
  6. West M., Nicholls K., Mehta A. et al.  Agalsidase-alfa and kidney dysfunction in Fabry disease. J Am Soc Nephrol 2009; 20: 1132-1139.
  7. Schiffmann R., Warnock D.G., Banikazemi M. et al.  Fabry disease: progression of nephropathy, and prevalence of cardiac and cerebrovascular events before enzyme replacement therapy. Nephrol Dial Transplant 2009; 24: 2102-2111.
  8. Jefferson J.A., Nelson P.J., Najafian B., Shankland S.J.  Podocyte disorders: Core Curriculum 2011. Am. J Kidney Dis 2011; 58 (4): 666-677.
  9. Fogo A.B., Bostad L., Svarstad E.  et al.; all members of the International Study Group of Fabry Nephropathy (ISGFN). Scoring system for renal pathology in Fabry disease: report of the International Study Group of Fabry Nephropathy (ISGFN). Nephrol Dial Transplant 2010; 25 (7): 2168-2177.
  10. Najafian B., Mauer M., Hopkin R.J., Svarstad E.  Renal complications of Fabry disease in children. Pediatr Nephrol 2013; 28 (5): 679-685.
  11. Eng C.M., Germain D.P., Banikazemi M. et al.  Fabry disease: Guidelines for the evaluation and management of multi-organ system involvement. Genetics in Medicine 2006; 8 (9): 539-548.
  12. Mehta A., Ricci R., Widmer U. et al.  Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey. Eur J Clin Invest 2004; 34: 236-242.
  13. Whybra C., Miebach E., Mengel E. et al.  A 4-year study of the efficacy and tolerability of enzyme replacement therapy with agalsidase-alfa in 36 women with Fabry disease. Genet Med 2009; 11: 441-449.
  14. Pisani A., Visciano B., Roux G.D. et al.  Enzyme replacement therapy in patients with Fabry disease: state of the art and review of the literature. Mol Genet Metab 2012; 107 (3): 267-275.
  15. Tahir H., Jackson L.L., Warnock D.G.  Antiproteinuric therapy and Fabry nephropathy: sustained reduction of proteinuria in patients receiving enzyme replacement therapy with agalsidase-beta. J Am Soc Nephrol 2007; 18: 2609-2617.
  16. Levey A.S.  Clinical practice. Nondiabetic kidney disease. N Engl J Med 2002; 347: 1505-1511.
  17. Mehta A., West M.L., Pintos-Morell G. et al.  Therapeutic goals in the treatment of Fabry disease. Genetics in Medicine 2010; 12 (11): 713-720.
  18. Maixnerová D., Tesa V., Ry Avá R. et al.  The coincidence of IgA nephropathy and Fabry disease. BMC Nephrology 2013; 14 (1): 6.
  19. Kakita T., Nagatoya K., Mori T. et al.  Coincidental finding of Fabry's disease in a patient with IgA nephropathy. Nephol Dial Transplant 2010; 3: 443-446.
  20. Shimohata H., Yoh K., Takada K. et al.  Hemizygous Fabry disease associated with IgA nephropathy: a case report. J Nephrol 2009; 22 (5): 682-684.
  21. Zarate Y.A, Patterson L., Yin H. et al.  A case of minimal change disease in a Fabry patient. Pediatr Nephrol 2009; 25 (3): 553-556.
  22. Singh H.K., Nickeleit V., Kriegsmann J. et al.  Coexistence of Fabry's disease and necrotizing and crescentic glomerulonephritis. Clin Nephrol 2001; 55 (1): 73-79.
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.